Advertisement
News
Advertisement

NuVasive wins FDA approval for PCM spine implant

Fri, 10/26/2012 - 12:38pm
Mass Device

NuVasive says the FDA granted pre-market approval to its PCM cervical disc system, sending shares up on Wall Street today.

NuVasive

NuVasive Inc. (NSDQ:NUVA) said the FDA granted pre-market approval for its PCM cervical disc implant, sending NUVA shares up more than 2% on Wall Street today.

The San Diego-based medical device company said the implant is designed to preserve motion in the cervical spine, in lieu of a standard fusion procedure. The FDA nod came after a 403-patient investigation device exemption trial, according to NuVasive.

NUVA shares were trading at $14.23 as of about 12:30 p.m. today, up 2.3%.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading